[[[], false, "batio_savach", null, [], null, "text", "t2_3m6w99jo", false, false, [], false, false, 1608151116, "self.stocks", "https://www.reddit.com/r/stocks/comments/kehepa/ctsh_buybacks/", {}, "kehepa", true, false, false, false, true, true, false, "", [], "dark", "text", false, false, true, 1, 0, false, "all_ads", "/r/stocks/comments/kehepa/ctsh_buybacks/", false, 6, 1608151126, 1, "I am looking into Cognizant, and I saw that they are doing $9.5B worth of buybacks. My intuition tells me that this will increase the stock price, but I was hoping someone could help me understand this better. Preliminary google searches tell me that it can be used for companies to provide equity and stocks to employees but is also seen as favorable in the market", true, false, false, "stocks", "t5_2qjfk", 972112, "public", "self", "$CTSH buybacks", 0, [], 1.0, "https://www.reddit.com/r/stocks/comments/kehepa/ctsh_buybacks/", "all_ads", 6, 1608147516.0, {"all_awardings": [], "allow_live_comments": false, "author": "batio_savach", "author_flair_css_class": null, "author_flair_richtext": [], "author_flair_text": null, "author_flair_type": "text", "author_fullname": "t2_3m6w99jo", "author_patreon_flair": false, "author_premium": false, "awarders": [], "can_mod_post": false, "contest_mode": false, "created_utc": 1608151116, "domain": "self.stocks", "full_link": "https://www.reddit.com/r/stocks/comments/kehepa/ctsh_buybacks/", "gildings": {}, "id": "kehepa", "is_crosspostable": true, "is_meta": false, "is_original_content": false, "is_reddit_media_domain": false, "is_robot_indexable": true, "is_self": true, "is_video": false, "link_flair_background_color": "", "link_flair_richtext": [], "link_flair_text_color": "dark", "link_flair_type": "text", "locked": false, "media_only": false, "no_follow": true, "num_comments": 1, "num_crossposts": 0, "over_18": false, "parent_whitelist_status": "all_ads", "permalink": "/r/stocks/comments/kehepa/ctsh_buybacks/", "pinned": false, "pwls": 6, "retrieved_on": 1608151126, "score": 1, "selftext": "I am looking into Cognizant, and I saw that they are doing $9.5B worth of buybacks. My intuition tells me that this will increase the stock price, but I was hoping someone could help me understand this better. Preliminary google searches tell me that it can be used for companies to provide equity and stocks to employees but is also seen as favorable in the market", "send_replies": true, "spoiler": false, "stickied": false, "subreddit": "stocks", "subreddit_id": "t5_2qjfk", "subreddit_subscribers": 972112, "subreddit_type": "public", "thumbnail": "self", "title": "$CTSH buybacks", "total_awards_received": 0, "treatment_tags": [], "upvote_ratio": 1.0, "url": "https://www.reddit.com/r/stocks/comments/kehepa/ctsh_buybacks/", "whitelist_status": "all_ads", "wls": 6, "created": 1608147516.0}], [[], false, "spacej3di", null, [], null, "text", "t2_kdm2ull", false, false, [], false, false, 1603982034, "self.stocks", "https://www.reddit.com/r/stocks/comments/jkb4jd/morning_market_synopsis_thursday_oct_29_2020/", {}, "jkb4jd", true, false, false, false, true, true, false, "", "resources", [], "a376614c-65e6-11e5-b6e7-123c7cc7e97b", "Resources", "dark", "text", false, false, true, 0, 0, false, "all_ads", "/r/stocks/comments/jkb4jd/morning_market_synopsis_thursday_oct_29_2020/", false, 6, 1603982045, 1, "**US equities mostly higher: Dow +0.29%, S&amp;P 500 +0.78%, Nasdaq +1.18%, Russell 2000 +0.10%**\n\n* US equities mostly higher in Thursday morning trading after selling off sharply on Wednesday with the S&amp;P falling for its third straight session, declining the most since June. Communications services and tech rallying into big tech results after the close. Healthcare, utilities and financials the decliners. Treasuries narrowly mixed. Dollar better vs major currencies. Gold down 0.2%. WTI crude down 4.4%, hitting lowest levels since June.\n* Nothing specific behind the choppy price action as the market narrative remains largely unchanged. **Biggest concerns right now revolve around resurgent coronavirus cases and accompanying mitigation measures, vaccine delays, lack of near-term fiscal stimulus and potential for a contested election**. Some of these concerns have helped to overshadow strong Q3 earnings season metrics though there have also been thoughts that a lot of good news has already been priced in. Central bank liquidity tailwind still seen as the biggest positive for stocks. Corporate profit resilience another key part of the bullish narrative. Strategists have also discussed how the market has warmed up to prospects for meaningful fiscal stimulus if Democrats sweep.\n* **Initial claims** better than expected, hitting lowest level since mid-March. **Q3 GDP** expanded a slightly larger-than-expected 33.1% but best quarter on record followed worst quarter of all time. **ECB** left policy unchanged but hinted it could recalibrate in December. **Coronavirus** **headlines downbea**t following European lockdowns yesterday with record cases in US, more concerns about hospital capacity pressures, and Fauci saying US may not return to normal until 2022. WSJ latest to highlight **massive budget pressures at the state level**. Reuters reported that if elected, **Biden would consult with allies on future of US tariffs on China.**\n* **More than half of S&amp;P 500 has now reported** following latest flurry of results. **Beat rates still every elevated and have moved higher over the last 24 hours** after trending down a bit earlier this week. Nothing too surprising from a thematic perspective with **companies leveraged to at-home trends (work, watch, listen, eat) still reporting some of the best results**. Auto and housing exposure also bright spots. Travel and cross-border exposure still a headwind. Cost-cutting still a big area of focus from a margin perspective. **Factors such as expectations and sustainability also playing a role in the post-earnings price action**.\n* In terms of some of the higher-profile earnings, **V-US** results better than rival MA-US with help from debit and US exposure. **AMGN-US** guidance raise seemed to underwhelm. **NOW-US** subscription revenue and billings beat and management commentary positive. **SPOT-US** revenue (and guide) light but sub and engagement metrics better. **EBAY-US** beat but GMV growth slowed and active users missed. **PINS-US** beat big and guided above on leverage to at-home trends. **KHC-US** boosted by at-home consumption tailwind. Outside of earnings, **MRVL-US** under pressure on acquisition of **IPHI-US** .\n\n**Notable Gainers:**\n\n* \\+37.9% **PINS-US** (Pinterest): Big Q3 earnings and revenue beat; MAU growth and ARPU stronger; highlighted supportive macro environment with advertising demand improving; saw boost from investments with auto bid a meaningful contributor; Q4 revenue guidance well ahead of the Street.\n* \\+19.6% **IPHI-US** (Inphi Corp): To be acquired by MRVL-US in cash and stock transaction expected to close by 2H21; $66 per share price and 2.323 shares of common stock represents a premium of 42.2%; Q3 earnings were slightly ahead, though revenue and guidance in line with published consensus while some analysts calling for a strong beat and raise.\n* \\+9.9% **TPR-US** (Tapestry): FQ1 EPS, revenue beat; did not provide FY21 guidance, but said it expects MSD revenue growth against +3.0% consensus, including LSD Q2 sales decline against Street expectation for 14% decline; analysts highlighted margin strength on fewer promotions, more visibility on FY21 trajectory.\n* \\+7% **CTSH-US** (Cognizant Technology): Q3 revenue and EPS better; bookings growth accelerated slightly from 1H on Digital bookings strength; raised 2020 revenue guidance to high end of prior range, with EPS outlook also up; takeaways focused on improved healthcare performance, upbeat pipeline commentary, favorable cash actions; upgraded at Cowen on material progress on restructuring.\n* \\+6.5% **PPC-US** (Pilgrim's Pride): Q3 earnings and revenue beat; highlighted demand recovery within fresh operations; noted Retail and QSR businesses especially strong; said Mexican results strong and European operations continuing to improve.\n* \\+6.2% **F-US** (Ford): Q3 earnings beat strongly on margin gains from positive product mix (strong pickup sales) though revenue missed overall, guided Q4 ahead of expectations; analysts noted particular strength in North America and Ford Credit, free cash flow beat; also tailwinds from COVID-related cost reductions, strong selling prices, tight inventory, strong used car prices.\n* \\+4.4% **IDXX-US** (IDEXX Labs): Q3 earnings and revenue beat though no guidance provided; analysts noted strong results exceeded very high expectations driven by Companion Animal Group Diagnostics, operating margins increased, pet market growth tailwind.\n* \\+3.9% **TAP-US** (Molson Coors Beverage): Big Q3 EPS and EBITDA beat; takeaways noted better revenue growth, stronger pricing, lower marketing expense, better-than-feared performance in NA and Europe, increased production capacity for stronger brands, no guidance, worries about new lockdowns in Europe, and very low expectations/depressed sentiment into the print.\n* \\+2.7% **NOW-US** (ServiceNow): Q3 key metrics ahead, including subscription revenue and subscription billings and operating margin; also raised FY 20 guidance; Street takeaways focused on execution, upbeat management commentary, outsized RPO growth, growth in &gt;$1M+ ACV customers, strong renewal rates, record federal contribution, investments and broader digital transformation leverage.\n* \\+1.3% **CGNX-US** (Cognex): Q3 earnings and revenue beat; GM improved sequentially; highlighted growth in consumer electronics and e-commerce and said automotive drag lessened q/q; Q4 revenue guide beat; sees continued growth in consumer, logistics, medical-related, and semi.\n* \\+1.2% **URI-US** (United Rentals): Q3 earnings and revenue beat; equipment sales a bright spot; fleet productivity better q/q; raised FY EBITDA guidance citing continued steady improvement in most markets; analyst generally positive on cost controls.\n\n**Notable Decliners:**\n\n* \\-9.5% **ABMD-US** (Abiomed): FQ2 revenue beat; Impella results better with sequential improvement across all geographic regions; GM and OM lower y/y; next-Q revenue guide light; analysts noted results somewhat underwhelming relative to June-Q performance.\n* \\-8.5% **MRVL-US** (Marvell): To acquire IPHI-US in cash and stock transaction expected to close by 2H21; financing commitment received; $66 per share price and 2.323 shares of common stock represents a premium of 42.2%; combined company will domicile in US; expected to realize $125M in synergies within 18 months and be accretive in first year; analysts noted EPS dilution out of the gate but complementary product sets including data center market.\n* \\-7.7% **EBAY-US** (eBay): Q3 EPS, revenue beat; GMV beat driven by US upside, though active buyers missed; guided Q4 and FY20 EPS, revenue guidance ahead of estimates; analysts noted q/q GMV, user growth slowdown a cautious signal for 2021.\n* \\-5.2% **FIS-US** (Fidelity National Information): Q3 earnings and revenue largely in line; Merchant Solutions organic growth flat with segment margin weaker; Banking Solutions revenue missed; analysts noted organic growth pressured by ongoing SMB and cross-border yield pressure.\n* \\-4.3% **CHD-US** (Church &amp; Dwight): Q3 earnings and revenue better; organic growth ahead though OM missed; Consumer domestic sales strength saw some offset by lower price and mix; Q4 and FY revenue growth guidance better but EPS guide below consensus.\n* \\-3.8% **ETSY-US** (Etsy): Q3 EPS, EBITDA, revenue all beat; ending active sellers and buyers ahead; guided Q4 EBITDA, revenue ahead of Street; management said mask sales strength setting up difficult 2021 comps; analysts cautious on GMS per user deceleration, which implies frequency already declining; also cautious on margin outlook as peak ecomm environment fades.\n* \\-2.4% **TDOC-US** (Teladoc Health, Inc.): Q3 earnings, revenue, and GM better; visit volumes higher from non-Covid cases but visit fee growth weaker; raised FY guidance while Q4 EPS guide brackets consensus; analysts pointed to high expectations and cautious on valuation.\n* \\-2.4% **LVGO-US** (Livongo Health, Inc.): Q3 earnings and revenue were ahead, guidance raised; analysts noted shareholder vote to approve merger with TDOC-US is today and shares have nearly quintupled this year supported by Covid-impacts, free cash flow was negative, though results strong with margins and client base both increasing.\n* \\-2.2% **GILD-US** (Gilead Sciences): Q3 earnings and revenue better; analysts noted some growth in HIV franchise but ongoing weakness in HCV; lowered top end of FY EPS and sales guidance on remdesivir uncertainty (noted lower hospital use and stockpiling).\n* \\-1.9% **GPN-US** (Global Payments): Q3 EPS, operating income beat, revenue in line; increased share repurchase authorization; analysts cautious on decline in merchant acquiring given strong ecomm backdrop, especially given strong FISV-US organic growth.\n\n09:29:17 AM CDT on 29 Oct '20", true, false, false, "stocks", "t5_2qjfk", 891775, "public", "self", "Morning Market Synopsis - Thursday, Oct. 29, 2020", 0, [], 1.0, "https://www.reddit.com/r/stocks/comments/jkb4jd/morning_market_synopsis_thursday_oct_29_2020/", "all_ads", 6, 1603978434.0, {"all_awardings": [], "allow_live_comments": false, "author": "spacej3di", "author_flair_css_class": null, "author_flair_richtext": [], "author_flair_text": null, "author_flair_type": "text", "author_fullname": "t2_kdm2ull", "author_patreon_flair": false, "author_premium": false, "awarders": [], "can_mod_post": false, "contest_mode": false, "created_utc": 1603982034, "domain": "self.stocks", "full_link": "https://www.reddit.com/r/stocks/comments/jkb4jd/morning_market_synopsis_thursday_oct_29_2020/", "gildings": {}, "id": "jkb4jd", "is_crosspostable": true, "is_meta": false, "is_original_content": false, "is_reddit_media_domain": false, "is_robot_indexable": true, "is_self": true, "is_video": false, "link_flair_background_color": "", "link_flair_css_class": "resources", "link_flair_richtext": [], "link_flair_template_id": "a376614c-65e6-11e5-b6e7-123c7cc7e97b", "link_flair_text": "Resources", "link_flair_text_color": "dark", "link_flair_type": "text", "locked": false, "media_only": false, "no_follow": true, "num_comments": 0, "num_crossposts": 0, "over_18": false, "parent_whitelist_status": "all_ads", "permalink": "/r/stocks/comments/jkb4jd/morning_market_synopsis_thursday_oct_29_2020/", "pinned": false, "pwls": 6, "retrieved_on": 1603982045, "score": 1, "selftext": "**US equities mostly higher: Dow +0.29%, S&amp;P 500 +0.78%, Nasdaq +1.18%, Russell 2000 +0.10%**\n\n* US equities mostly higher in Thursday morning trading after selling off sharply on Wednesday with the S&amp;P falling for its third straight session, declining the most since June. Communications services and tech rallying into big tech results after the close. Healthcare, utilities and financials the decliners. Treasuries narrowly mixed. Dollar better vs major currencies. Gold down 0.2%. WTI crude down 4.4%, hitting lowest levels since June.\n* Nothing specific behind the choppy price action as the market narrative remains largely unchanged. **Biggest concerns right now revolve around resurgent coronavirus cases and accompanying mitigation measures, vaccine delays, lack of near-term fiscal stimulus and potential for a contested election**. Some of these concerns have helped to overshadow strong Q3 earnings season metrics though there have also been thoughts that a lot of good news has already been priced in. Central bank liquidity tailwind still seen as the biggest positive for stocks. Corporate profit resilience another key part of the bullish narrative. Strategists have also discussed how the market has warmed up to prospects for meaningful fiscal stimulus if Democrats sweep.\n* **Initial claims** better than expected, hitting lowest level since mid-March. **Q3 GDP** expanded a slightly larger-than-expected 33.1% but best quarter on record followed worst quarter of all time. **ECB** left policy unchanged but hinted it could recalibrate in December. **Coronavirus** **headlines downbea**t following European lockdowns yesterday with record cases in US, more concerns about hospital capacity pressures, and Fauci saying US may not return to normal until 2022. WSJ latest to highlight **massive budget pressures at the state level**. Reuters reported that if elected, **Biden would consult with allies on future of US tariffs on China.**\n* **More than half of S&amp;P 500 has now reported** following latest flurry of results. **Beat rates still every elevated and have moved higher over the last 24 hours** after trending down a bit earlier this week. Nothing too surprising from a thematic perspective with **companies leveraged to at-home trends (work, watch, listen, eat) still reporting some of the best results**. Auto and housing exposure also bright spots. Travel and cross-border exposure still a headwind. Cost-cutting still a big area of focus from a margin perspective. **Factors such as expectations and sustainability also playing a role in the post-earnings price action**.\n* In terms of some of the higher-profile earnings, **V-US** results better than rival MA-US with help from debit and US exposure. **AMGN-US** guidance raise seemed to underwhelm. **NOW-US** subscription revenue and billings beat and management commentary positive. **SPOT-US** revenue (and guide) light but sub and engagement metrics better. **EBAY-US** beat but GMV growth slowed and active users missed. **PINS-US** beat big and guided above on leverage to at-home trends. **KHC-US** boosted by at-home consumption tailwind. Outside of earnings, **MRVL-US** under pressure on acquisition of **IPHI-US** .\n\n**Notable Gainers:**\n\n* \\+37.9% **PINS-US** (Pinterest): Big Q3 earnings and revenue beat; MAU growth and ARPU stronger; highlighted supportive macro environment with advertising demand improving; saw boost from investments with auto bid a meaningful contributor; Q4 revenue guidance well ahead of the Street.\n* \\+19.6% **IPHI-US** (Inphi Corp): To be acquired by MRVL-US in cash and stock transaction expected to close by 2H21; $66 per share price and 2.323 shares of common stock represents a premium of 42.2%; Q3 earnings were slightly ahead, though revenue and guidance in line with published consensus while some analysts calling for a strong beat and raise.\n* \\+9.9% **TPR-US** (Tapestry): FQ1 EPS, revenue beat; did not provide FY21 guidance, but said it expects MSD revenue growth against +3.0% consensus, including LSD Q2 sales decline against Street expectation for 14% decline; analysts highlighted margin strength on fewer promotions, more visibility on FY21 trajectory.\n* \\+7% **CTSH-US** (Cognizant Technology): Q3 revenue and EPS better; bookings growth accelerated slightly from 1H on Digital bookings strength; raised 2020 revenue guidance to high end of prior range, with EPS outlook also up; takeaways focused on improved healthcare performance, upbeat pipeline commentary, favorable cash actions; upgraded at Cowen on material progress on restructuring.\n* \\+6.5% **PPC-US** (Pilgrim's Pride): Q3 earnings and revenue beat; highlighted demand recovery within fresh operations; noted Retail and QSR businesses especially strong; said Mexican results strong and European operations continuing to improve.\n* \\+6.2% **F-US** (Ford): Q3 earnings beat strongly on margin gains from positive product mix (strong pickup sales) though revenue missed overall, guided Q4 ahead of expectations; analysts noted particular strength in North America and Ford Credit, free cash flow beat; also tailwinds from COVID-related cost reductions, strong selling prices, tight inventory, strong used car prices.\n* \\+4.4% **IDXX-US** (IDEXX Labs): Q3 earnings and revenue beat though no guidance provided; analysts noted strong results exceeded very high expectations driven by Companion Animal Group Diagnostics, operating margins increased, pet market growth tailwind.\n* \\+3.9% **TAP-US** (Molson Coors Beverage): Big Q3 EPS and EBITDA beat; takeaways noted better revenue growth, stronger pricing, lower marketing expense, better-than-feared performance in NA and Europe, increased production capacity for stronger brands, no guidance, worries about new lockdowns in Europe, and very low expectations/depressed sentiment into the print.\n* \\+2.7% **NOW-US** (ServiceNow): Q3 key metrics ahead, including subscription revenue and subscription billings and operating margin; also raised FY 20 guidance; Street takeaways focused on execution, upbeat management commentary, outsized RPO growth, growth in &gt;$1M+ ACV customers, strong renewal rates, record federal contribution, investments and broader digital transformation leverage.\n* \\+1.3% **CGNX-US** (Cognex): Q3 earnings and revenue beat; GM improved sequentially; highlighted growth in consumer electronics and e-commerce and said automotive drag lessened q/q; Q4 revenue guide beat; sees continued growth in consumer, logistics, medical-related, and semi.\n* \\+1.2% **URI-US** (United Rentals): Q3 earnings and revenue beat; equipment sales a bright spot; fleet productivity better q/q; raised FY EBITDA guidance citing continued steady improvement in most markets; analyst generally positive on cost controls.\n\n**Notable Decliners:**\n\n* \\-9.5% **ABMD-US** (Abiomed): FQ2 revenue beat; Impella results better with sequential improvement across all geographic regions; GM and OM lower y/y; next-Q revenue guide light; analysts noted results somewhat underwhelming relative to June-Q performance.\n* \\-8.5% **MRVL-US** (Marvell): To acquire IPHI-US in cash and stock transaction expected to close by 2H21; financing commitment received; $66 per share price and 2.323 shares of common stock represents a premium of 42.2%; combined company will domicile in US; expected to realize $125M in synergies within 18 months and be accretive in first year; analysts noted EPS dilution out of the gate but complementary product sets including data center market.\n* \\-7.7% **EBAY-US** (eBay): Q3 EPS, revenue beat; GMV beat driven by US upside, though active buyers missed; guided Q4 and FY20 EPS, revenue guidance ahead of estimates; analysts noted q/q GMV, user growth slowdown a cautious signal for 2021.\n* \\-5.2% **FIS-US** (Fidelity National Information): Q3 earnings and revenue largely in line; Merchant Solutions organic growth flat with segment margin weaker; Banking Solutions revenue missed; analysts noted organic growth pressured by ongoing SMB and cross-border yield pressure.\n* \\-4.3% **CHD-US** (Church &amp; Dwight): Q3 earnings and revenue better; organic growth ahead though OM missed; Consumer domestic sales strength saw some offset by lower price and mix; Q4 and FY revenue growth guidance better but EPS guide below consensus.\n* \\-3.8% **ETSY-US** (Etsy): Q3 EPS, EBITDA, revenue all beat; ending active sellers and buyers ahead; guided Q4 EBITDA, revenue ahead of Street; management said mask sales strength setting up difficult 2021 comps; analysts cautious on GMS per user deceleration, which implies frequency already declining; also cautious on margin outlook as peak ecomm environment fades.\n* \\-2.4% **TDOC-US** (Teladoc Health, Inc.): Q3 earnings, revenue, and GM better; visit volumes higher from non-Covid cases but visit fee growth weaker; raised FY guidance while Q4 EPS guide brackets consensus; analysts pointed to high expectations and cautious on valuation.\n* \\-2.4% **LVGO-US** (Livongo Health, Inc.): Q3 earnings and revenue were ahead, guidance raised; analysts noted shareholder vote to approve merger with TDOC-US is today and shares have nearly quintupled this year supported by Covid-impacts, free cash flow was negative, though results strong with margins and client base both increasing.\n* \\-2.2% **GILD-US** (Gilead Sciences): Q3 earnings and revenue better; analysts noted some growth in HIV franchise but ongoing weakness in HCV; lowered top end of FY EPS and sales guidance on remdesivir uncertainty (noted lower hospital use and stockpiling).\n* \\-1.9% **GPN-US** (Global Payments): Q3 EPS, operating income beat, revenue in line; increased share repurchase authorization; analysts cautious on decline in merchant acquiring given strong ecomm backdrop, especially given strong FISV-US organic growth.\n\n09:29:17 AM CDT on 29 Oct '20", "send_replies": true, "spoiler": false, "stickied": false, "subreddit": "stocks", "subreddit_id": "t5_2qjfk", "subreddit_subscribers": 891775, "subreddit_type": "public", "thumbnail": "self", "title": "Morning Market Synopsis - Thursday, Oct. 29, 2020", "total_awards_received": 0, "treatment_tags": [], "upvote_ratio": 1.0, "url": "https://www.reddit.com/r/stocks/comments/jkb4jd/morning_market_synopsis_thursday_oct_29_2020/", "whitelist_status": "all_ads", "wls": 6, "created": 1603978434.0}], [[], false, "t3chb1zn3ss", null, [], null, "text", "t2_5cp2dqlf", false, false, [], false, false, 1580458094, "self.stocks", "https://www.reddit.com/r/stocks/comments/ewl7aj/if_you_had_25k_to_enter_the_market_tomorrow_what/", {}, "ewl7aj", true, false, false, false, true, true, false, "", [], "dark", "text", false, false, true, 30, 0, false, "all_ads", "/r/stocks/comments/ewl7aj/if_you_had_25k_to_enter_the_market_tomorrow_what/", false, 6, 1580458095, 1, "If you had 25K to enter the market tomorrow, what would you invest in?  Why?\n\nI'm interested in seeing what the responses will be.\n\nThese are the stocks I've been swinging lately:\n\nAAPL, ACN, ADSK, AMD, AMZN, BABA, BR, BZUN, C, COLL, CMG, CRM, CSCO, CTSH, DIS, DOX, EWZ, FB, GE, GOOGL, GPRO, GS, HTBX, MSFT, NET, NFLX, NKE, NVDA, OKTA, SBUX, SEIC, SHOP, SNA, SPOT, SQ, TEAM, TSLA, TTWO, TWTR, UBER, UPWK, V, WDAY, WORK, YEXT, ZEN, and ZS.\n\nMy largest position is in Apple, which I continue to add to and will hold until it reaches $1K per share.  At that point, I'll decide whether to sell.  $1K is a long ways away .... or is it?", true, false, false, "stocks", "t5_2qjfk", 478679, "public", "self", "If you had 25K to enter the market tomorrow, what would you invest in?", 0, "https://www.reddit.com/r/stocks/comments/ewl7aj/if_you_had_25k_to_enter_the_market_tomorrow_what/", "all_ads", 6, 1580454494.0, {"all_awardings": [], "allow_live_comments": false, "author": "t3chb1zn3ss", "author_flair_css_class": null, "author_flair_richtext": [], "author_flair_text": null, "author_flair_type": "text", "author_fullname": "t2_5cp2dqlf", "author_patreon_flair": false, "author_premium": false, "awarders": [], "can_mod_post": false, "contest_mode": false, "created_utc": 1580458094, "domain": "self.stocks", "full_link": "https://www.reddit.com/r/stocks/comments/ewl7aj/if_you_had_25k_to_enter_the_market_tomorrow_what/", "gildings": {}, "id": "ewl7aj", "is_crosspostable": true, "is_meta": false, "is_original_content": false, "is_reddit_media_domain": false, "is_robot_indexable": true, "is_self": true, "is_video": false, "link_flair_background_color": "", "link_flair_richtext": [], "link_flair_text_color": "dark", "link_flair_type": "text", "locked": false, "media_only": false, "no_follow": true, "num_comments": 30, "num_crossposts": 0, "over_18": false, "parent_whitelist_status": "all_ads", "permalink": "/r/stocks/comments/ewl7aj/if_you_had_25k_to_enter_the_market_tomorrow_what/", "pinned": false, "pwls": 6, "retrieved_on": 1580458095, "score": 1, "selftext": "If you had 25K to enter the market tomorrow, what would you invest in?  Why?\n\nI'm interested in seeing what the responses will be.\n\nThese are the stocks I've been swinging lately:\n\nAAPL, ACN, ADSK, AMD, AMZN, BABA, BR, BZUN, C, COLL, CMG, CRM, CSCO, CTSH, DIS, DOX, EWZ, FB, GE, GOOGL, GPRO, GS, HTBX, MSFT, NET, NFLX, NKE, NVDA, OKTA, SBUX, SEIC, SHOP, SNA, SPOT, SQ, TEAM, TSLA, TTWO, TWTR, UBER, UPWK, V, WDAY, WORK, YEXT, ZEN, and ZS.\n\nMy largest position is in Apple, which I continue to add to and will hold until it reaches $1K per share.  At that point, I'll decide whether to sell.  $1K is a long ways away .... or is it?", "send_replies": true, "spoiler": false, "stickied": false, "subreddit": "stocks", "subreddit_id": "t5_2qjfk", "subreddit_subscribers": 478679, "subreddit_type": "public", "thumbnail": "self", "title": "If you had 25K to enter the market tomorrow, what would you invest in?", "total_awards_received": 0, "url": "https://www.reddit.com/r/stocks/comments/ewl7aj/if_you_had_25k_to_enter_the_market_tomorrow_what/", "whitelist_status": "all_ads", "wls": 6, "created": 1580454494.0}]]